Conference
Physician Factors Determining Treatment Decisions in Selecting Second Line Agents for Pediatric ITP
Abstract
Abstract
Background: Decision-making in selecting second-line therapies for pediatric patients with immune thrombocytopenia (ITP) has not been studied. Using data collected from physicians experienced in treating ITP, we developed a conceptual model of factors that informed treatment choice. This study was a component of ICON1, a prospective, observational, longitudinal cohort study of second line treatments for childhood ITP …
Authors
Lambert MP; Grace RF; Neunert C; Despotovic JM; Bhat R; Pastore YD; Buchanan GR; Klaassen RJ; Bennett CM; Rothman JA
Volume
128
Publisher
American Society of Hematology
Publication Date
December 2, 2016
DOI
10.1182/blood.v128.22.1008.1008
Conference proceedings
Blood
Issue
22
ISSN
0006-4971